Skip to content

International Conference on Drug Discovery and Translational Medicine 2025 (ICDDTM'25)

Fostering Global Interdisciplinary Collaboration for Sustainable Innovation in Drug Discovery and Translational Medicine

Venue: Hospital Sultan Abdul Aziz Shah (HSAAS), Universiti Putra Malaysia (UPM), Serdang, Selangor
Date: 24-25 November (Pre-Conference Workshops) & 26-27 November 2025 (ICDDTM'25 Conference)
Menu
  • Home
    • Welcome and Selamat Datang
    • Committee Members
    • Gallery
    • The Venue
      • Nearby Hotels
  • Programme Schedule
    • Programme Schedule
    • Why You Should Attend
    • Plenary & Invited Speakers
    • Pre-Conference Workshops
      • Pharmacometrics
      • Conducting Clinical Trials
      • AI and Machine Learning in Drug Discovery: From Target Identification to Personalised Medicine
      • Network Pharmacology
      • All Topics
    • Special Forums
    • ICDDTM’25 Posters
  • Register
  • Submit Abstract
    • Author’s Guideline
      For Abstract
      • General Guidelines For Oral Presentation
      • General Guidelines For Poster Presentation
    • Awards
      • Travel Awards
  • Contact
  • F.A.Q.
  • Be A Sponsor
Menu

Prof. Paul Chi-Lui Ho

Prof. Paul Chi-Lui Ho
Pharmaceutical Science
Monash University, Malaysia

———————————————————————-

Professor Paul C. Ho, a pharmaceutical scientist, earned his B. Pharm. (Hons) and Ph.D. from the University of Queensland and completed post-doctoral fellowships at the University of Michigan and the Queensland Institute of Medical Research.

Currently, he holds prestigious positions as Professor of Pharmacy at Monash University Malaysia, Emeritus Professor at the National University of Singapore (NUS), and Honorary Professor at Xi’an Jiaotong University. With over 200 publications in top-tier journals like Biomaterials, Small, Nature Medicine, Asian Journal of Pharmaceutical Sciences, and JACS, and an H-index of 55, Professor Ho has made significant contributions to pharmacokinetics, exploring how disease states and organ functions influence drug behavior. His research has expanded into biomarkers and omics studies, leveraging advanced technologies to improve personalized medicine. Recognized for his expertise, he received the AAPS Outstanding Medical Graduate Drug Technology Mentor Award and the NUS Distinguished Scientist Award in 2011.

Beyond academia, he serves as a consultant to pharmaceutical companies, reviews research proposals for international agencies, and contributes to additive manufacturing, particularly in 3D printing for pharmaceuticals, as a thrust lead at AM@NUS. His multidisciplinary work continues to shape drug development and therapeutic innovation.

Note: Click [x] on top-right or anywhere outside this pop-up to exit

 

Category:

Venue:
Hospital Sultan Abdul Aziz Shah (HSAAS), Universiti Putra Malaysia (UPM), Serdang, Selangor

ICDDTM'25 Flyer

Right click and Save As ICDDTM'25 Poster

All abstracts will be published in an indexed (Scopus or WoS) journal

Disclaimer

The information on this website is regularly updated to reflect the latest developments. While we strive for accuracy, details may change without prior notice.

All claims on the advertisements stated in this website are those of the vendors and journals and do not reflect the official position or endorsement from the organisers of ICDDTM'25. The organisers of ICDDTM'25 acknowledge the importance of having research data to substantiate all advertisement claims, and the research or citation is to be made available on the vendors’ and journals’ website or, where proprietary interests exist, be made available upon request.

Flag Counter
(Dr. D Y. Patil Dnyan Prasad University, Pune, India)
(Nirma University, India)
(University of Asia Pacific, Bangladesh)
(University of Gajah Mada, Indonesia)
(Birla Institute of Technology Mesra, India)
(The Halifax Institute, Canada)
(Jashore University of Science and Technology, Bangladesh)
(Yantai Affiliated Hospital of Binzhou Medical University, China)
(Universitas Andalas, Padang, Indonesia)
(Dhaka University, Bangladesh)
© 2025 International Conference on Drug Discovery and Translational Medicine 2025 (ICDDTM'25) | Organised by Malaysian Association for Cancer Research